Press "Enter" to skip to content

New patent for Kowa Co drug LIVALO

0
Copyright © DrugPatentWatch. Originally published at New patent for Kowa Co drug LIVALO

Annual Drug Patent Expirations for LIVALO
Annual Drug Patent Expirations for LIVALO

Livalo is a drug marketed by Kowa Co and is included in one NDA. It is available from one supplier. There are three patents protecting this drug and one Paragraph IV challenge.

LIVALO drug price trends.

Drug patent litigation for LIVALO.

This drug has fifty-eight patent family members in nineteen countries.

The generic ingredient in LIVALO is pitavastatin calcium. One supplier is listed for this compound. Additional details are available on the pitavastatin calcium profile page.

For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com

Copyright © DrugPatentWatch. Originally published at New patent for Kowa Co drug LIVALO
    Do NOT follow this link or you will be banned from the site!